From left: Dr. Kerry Lavender (PhD) and Dr. Joyce Wilson (PhD). (Photos: Submitted)

USask researchers explore therapeutics to fight COVID-19

Posted on

With COVID-19 ravaging the globe, the race is on to accelerate therapeutics research and find effective treatment options.

Two research teams in the College of Medicine at the University of Saskatchewan (USask) are hoping their work will do just that.

Dr. Kerry Lavender (PhD) and Dr. Joyce Wilson (PhD) are principal investigators of projects that received Canadian Institutes of Health Research (CIHR) rapid response funding. The funding initiative contributes to the national research response to the COVID-19 pandemic.

Lavender’s project is rapidly evaluating some highly promising therapeutics against COVID-19, using a humanized mouse model…..

Read More Impact Stories

Posted on
For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Posted on
McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Posted on
Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]